Skip to content

Development a Predictive Nomogram for Primary Ovarian Insufficiency

Development a Predictive Nomogram for Primary Ovarian Insufficiency

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02795000
Enrollment
260
Registered
2016-06-09
Start date
2016-10-31
Completion date
2018-07-31
Last updated
2018-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Ovarian Insufficiency

Keywords

Primary Ovarian Insufficiency, nomogram

Brief summary

The purpose of this research is to develop a predictive nomogram for primary ovarian insufficiency.

Detailed description

Many researches show primary ovarian insufficiency(POI) etiology is related with gene,immunization,iatrogenic, infection factors and social factors etc. In fact, approximate 70-90% POI have no definite cause, so a lot of patients don't know what will happen when they in occult stage of POI. In this research, researchers will investigate all possible factors in POI patients and normal women and select the valuable risk factor by integrated by statistical method to establish the reasonable predictive model. This study consists two stages.The fist stage is the model establishment, the second stage is the certificate and evaluate the model.

Interventions

None listed

Sponsors

Guangzhou University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* Age18--42 * Definite spontaneous last menstrual period * Informed consent for participating this research and could answer the questionnaires faithfully.

Exclusion criteria

* Congenital gonadal dysgenesis and non organic diseases lead to menstrual disorders. * Endocrine diseases such Polycystic ovary syndrome, hyperprolactinemia, dysfunctional uterine bleeding, low gonadotropin menstrual disorders and hyperthyreosis * Reproductive toxicity of drugs used * Release of chemotherapeutic drugs * Accept sex hormone medicine in recent 3 months * Pregnant and lactating women * With serious heart, liver, kidney and other diseases * With severe psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Draw the Primary Ovarian insufficiency normogram1yearsRetrospective Investigation on inclusion criteria populations through multivariate cox proportional hazards regression analysis of independent risk factors can enter the predictive model using R software based on regression coefficient related variables draw the corresponding nomogram (nomogram) .

Secondary

MeasureTime frameDescription
Verify and evaluate the evaluation of Primary Ovarian insufficiency normogram2yearsusing the bootstrap method nomogram for internal verification to reduce overfitting bias, the evaluation of the model to predict the risk of premature menopause conformity. In the study population data, select postmenopausal cases, the use of prediction of survival analysis model initial assessment model; select Not menopause an independent risk factor for the population were followed ovarian anti-Mullerian hormone (AMH) decreased the extent of menopause Age as a standard curve prediction, evaluation nomogram model predictive accuracy and clinical value of premature menopause, and finally provide the first Chinese people have the physical characteristics of premature menopause prediction model

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026